Resmed (ASX:RMD) Chief Financial Officer Brett Sandercock sold 1,000 of his shares in the company on the New York Stock Exchange, with an aggregate market value of roughly $238,980, according to a Monday filing with the Australian bourse.
Following the transaction, Brett now owns nearly 146.9 million shares and other units outstanding in the company, the filing said.